101 related articles for article (PubMed ID: 6815146)
1. Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 3. Incorporation of [14C]midecamycin acetate (MOM) into P. aeruginosa pretreated with cell wall-affecting antibiotics.
Kasai T; Tomita T; Kanegasaki S; Homma JY
J Antibiot (Tokyo); 1982 Aug; 35(8):1086-92. PubMed ID: 6815146
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 2. Combined effects of a macrolide with a fosfomycin and an aminoglycoside antibiotic.
Kasai T; Homma JY
J Antibiot (Tokyo); 1982 Jul; 35(7):858-65. PubMed ID: 6816781
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 1. Combined effects of a macrolide and a peptide antibiotic.
Kasai T; Homma JY
J Antibiot (Tokyo); 1982 Mar; 35(3):343-8. PubMed ID: 6281226
[TBL] [Abstract][Full Text] [Related]
4. Combined action of semisynthetic penicillin and macrolide antibiotic on Pseudomonas aeruginosa in vitro and in vivo.
Kawaharajo K; Kasai T; Homma JY
Jpn J Exp Med; 1979 Oct; 49(5):331-6. PubMed ID: 119075
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of the protein, SP127, which enhances the activity of macrolide antibiotics against Pseudomonas aeruginosa.
Kikuchi M; Nakao Y
J Antibiot (Tokyo); 1977 Mar; 30(3):215-20. PubMed ID: 405356
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.
Lamers RP; Burrows LL
Future Med Chem; 2016 Jun; 8(9):975-92. PubMed ID: 27228070
[TBL] [Abstract][Full Text] [Related]
7. [In vitro combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa. In vitro synergistic activities].
Iyama Y; Sato K; Okachi R
Jpn J Antibiot; 1985 Apr; 38(4):1022-8. PubMed ID: 3928940
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activity of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo.
Kitaura K; Mineura K; Nakamizo N; Shiba K; Ohmori M; Saito A; Ueda Y
J Antibiot (Tokyo); 1984 Dec; 37(12):1681-6. PubMed ID: 6441792
[TBL] [Abstract][Full Text] [Related]
9. L-forms of Pseudomonas aeruginosa.
Hubert EG; Potter CS; Hensley TJ; Cohen M; Kalmanson GM; Guze LB
Infect Immun; 1971 Jul; 4(1):60-72. PubMed ID: 5005286
[TBL] [Abstract][Full Text] [Related]
10. Cell wall characteristics of Pseudomonas aeruginosa and its carbenicillin-induced L-form.
White CJ; Horsman MR; Rowe PS; Howells KF
Acta Biol Acad Sci Hung; 1978; 29(1):67-74. PubMed ID: 112813
[TBL] [Abstract][Full Text] [Related]
11. Effect of antibiotics on the phagocytosis and killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leukocytes.
Nishida M; Mine Y; Nonoyama S; Yokota Y
Chemotherapy; 1976; 22(3-4):203-10. PubMed ID: 178484
[TBL] [Abstract][Full Text] [Related]
12. Glucose uptake of Pseudomonas aeruginosa and its carbenicillin-induced L-form [proceedings].
White CJ; Horsman MR; Rowe PS
Biochem Soc Trans; 1977; 5(6):1760-2. PubMed ID: 413753
[No Abstract] [Full Text] [Related]
13. Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa.
Hamou-Segarra M; Zamorano L; Vadlamani G; Chu M; Sanchez-Diener I; Juan C; Blazquez J; Hattie M; Stubbs KA; Mark BL; Oliver A
J Antimicrob Chemother; 2017 Feb; 72(2):448-454. PubMed ID: 27999022
[TBL] [Abstract][Full Text] [Related]
14. [In vivo combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa].
Sato K; Yamashita K; Okachi R
Jpn J Antibiot; 1986 Jun; 39(6):1487-93. PubMed ID: 3093728
[TBL] [Abstract][Full Text] [Related]
15. [In vitro combination effects of astromicin and beta-lactam antibiotics against CFS-sensitive and CFS-resistant Pseudomonas aeruginosa. In vitro synergistic activity].
Yamada H; Takeyama H; Watanabe E; Fukutani H; Saka Y; Suzuki K; Kameyama Y; Esaki J; Yamazaki H; Mori Y
Jpn J Antibiot; 1988 May; 41(5):478-84. PubMed ID: 3145991
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic.
Kawaharajo K; Sekizawa Y; Inoue M
J Antibiot (Tokyo); 1981 Apr; 34(4):436-42. PubMed ID: 6974163
[TBL] [Abstract][Full Text] [Related]
17. The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.
Kasetty G; Bhongir RKV; Papareddy P; Herwald H; Egesten A
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652240
[TBL] [Abstract][Full Text] [Related]
18. Electron microscopy of Pseudomonas aeruginosa treated with sulbenicillin and dibekacin.
Aonuma S; Ariji F; Oizumi K; Konno K
Tohoku J Exp Med; 1987 Jun; 152(2):119-28. PubMed ID: 3114912
[TBL] [Abstract][Full Text] [Related]
19. Cell-wall studies of Pseudomonas aeruginosa and its carbenicillin-induced L-form [proceedings].
Branford White CJ; Rowe PS; Horsman MR; Spicer AB
Biochem Soc Trans; 1977; 5(5):1496-8. PubMed ID: 411700
[No Abstract] [Full Text] [Related]
20. [Quantitative evaluation of the inhibitory action of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Kondo K; Hashiba M; Baba S
Jpn J Antibiot; 1997 Mar; 50 Suppl A():102-5. PubMed ID: 9597456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
